FDA Drug Shortage Strategy: Enforcement Discretion, Patient Public Relations
By
Martin Berman-Gorvine / Email the Author / “The Pink Sheet” DAILY Feb. 21, 2012
Word Count: 867 / Article # 14120221003
Executive Summary
Rapid approval of a new, preservative-free generic methotrexate and permission to import an unapproved version of doxorubicin touted at press conference as FDA emphasizes the success of administrative efforts.
Already a Subscriber?
Log in for complete access.
Log In
Questions?
Call Toll-Free (800) 332-2181 or +1 (908) 547-2159.